Norihiro Kaneko < Norihiro Nishimoto < Norihiro Okada

Facettes : Author.f Mesh.f AffPays.f

List of bibliographic references

Number of relevant bibliographic references: 54.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000004 (2005)	Masahiko Mihara [Japon] ; Norihiro Nishimoto ; Yoshiyuki Ohsugi	The therapy of autoimmune diseases by anti-interleukin-6 receptor antibody.
000006 (2005)	Norihiro Nishimoto	[Anti-IL-6 receptor antibody].
000009 (2005)	Norihiro Nishimoto [Japon]	Clinical studies in patients with Castleman's disease, Crohn's disease, and rheumatoid arthritis in Japan.
000018 (2006)	Norihiro Nishimoto [Japon]	Interleukin-6 in rheumatoid arthritis.
000028 (2006)	Norihiro Nishimoto	[IL-6 targetting therapy for inflammatory immune diseases].
000029 (2006)	Norihiro Nishimoto	[Anti-interleukin-6 receptor antibody therapy--from bedside to bench].
000030 (2006)	Norihiro Nishimoto [Japon] ; Tadamitsu Kishimoto	Interleukin 6: from bench to bedside.
000032 (2006)	Hideko Nakahara [Japon] ; Norihiro Nishimoto	Anti-interleukin-6 receptor antibody therapy in rheumatic diseases.
000034 (2007)	Naoko Yoshio-Hoshino [Japon] ; Yasuo Adachi ; Chieko Aoki ; Alexander Pereboev ; David T. Curiel ; Norihiro Nishimoto	Establishment of a new interleukin-6 (IL-6) receptor inhibitor applicable to the gene therapy for IL-6-dependent tumor.
000037 (2007)	Norihiro Nishimoto	[Clinical benefits of anti-human IL-6 receptor antibody therapy].
000042 (2007)	Norihiro Nishimoto [Japon] ; Jun Hashimoto ; Nobuyuki Miyasaka ; Kazuhiko Yamamoto ; Shinichi Kawai ; Tsutomu Takeuchi ; Norikazu Murata ; Désirée Van Der Heijde ; Tadamitsu Kishimoto	Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab.
000049 (2007)	Norihiro Nishimoto	[Humanized anti-human IL-6 receptor antibody, tocilizumab].
000053 (2008)	Morihiko Ishizaki [Japon] ; Tetsuro Sasada ; Akane Kunitomi ; Yoshiteru Konaka ; Masato Yagita ; Shutaro Gunji ; Michiyuki Kanai ; Norihiro Nishimoto ; Arimichi Takabayashi	Uneventful splenectomy and cholecystectomy in a patient treated with anti-interleukin-6 receptor antibody therapy.
000070 (2008)	Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Yukoh Aihara ; Shuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu Kishimoto	Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.
000072 (2008)	Norihiro Nishimoto [Japon] ; Hideko Nakahara ; Naoko Yoshio-Hoshino ; Toru Mima	Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody.
000077 (2008)	Yasuo Adachi [Japon] ; Naoko Yoshio-Hoshino ; Norihiro Nishimoto	The blockade of IL-6 signaling in rational drug design.
000091 (2009)	Hiroshi Fujiwara [Japon] ; Norihiro Nishimoto ; Yoshimasa Hamano ; Nobuyuki Asanuma ; Shunji Miki ; Soji Kasayama ; Masaki Suemura	Masked early symptoms of pneumonia in patients with rheumatoid arthritis during tocilizumab treatment: a report of two cases.
000092 (2009)	Hideko Nakahara [Japon] ; Toru Mima ; Naoko Yoshio-Hoshino ; Masato Matsushita ; Jun Hashimoto ; Norihiro Nishimoto	A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years.
000095 (2008)	Norihiro Nishimoto [Japon] ; Kimio Terao ; Toru Mima ; Hideko Nakahara ; Nobuhiro Takagi ; Takahiro Kakehi	Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease.
000109 (2008)	Norihiro Nishimoto	[Immunotherapy using IL-6 receptor as the target].
000110 (2009)	Norihiro Nishimoto [Japon] ; Nobuyuki Miyasaka ; Kazuhiko Yamamoto ; Shinichi Kawai ; Tsutomu Takeuchi ; Junichi Azuma ; Tadamitsu Kishimoto	Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Norihiro Nishimoto" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Norihiro Nishimoto" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Norihiro Nishimoto
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021